Literature DB >> 15499255

Myopia reduction using corneal refractive therapy contact lenses.

Bruce H Koffler1, Vivien M Smith.   

Abstract

PURPOSE: The Paragon corneal refractive therapy (CRT) lens provides a temporary reduction in myopia by molding the cornea while sleeping. This study presents our initial experience in 20 patients fit with the CRT lens.
METHODS: Myopic patients with a spherical correction between -1.00 and -7.75 diopters (D) and astigmatism less than 1.62 D were fit and followed for an average of 5.1 months.
RESULTS: Patients whose initial refraction was between -1.00 and -3.00 D achieved an average of 1.50 D myopic correction; those between -3.25 and -6.00 achieved an average of 2.9 D myopic correction; and those greater than -6.00 D averaged 5.8 D of correction. Uncorrected visual acuity improved an average of 7.7 lines. One hundred percent achieved 20/40 or better vision, and 55% achieved 20/20 vision. Fifty-five percent were within 0.50 D of plano, and 84% were within 1.00 D of plano. There was an overall 80% success rate.
CONCLUSIONS: The CRT lens is an effective modality for temporary myopic correction for a restricted subset of myopic candidates. Those with a spherical manifest refraction between -1.00 and -6.00 D and up to 1.50 D of astigmatism can expect a good outcome with these lenses.

Entities:  

Mesh:

Year:  2004        PMID: 15499255     DOI: 10.1097/01.icl.0000140228.24461.1b

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  2 in total

1.  To Achieve a Bullseye: Factors Related to Corneal Refractive Therapy Orthokeratology Lens Toricity.

Authors:  Changfei Li; Li Zeng; Jiaqi Zhou; Bingjie Wang; Zhi Chen
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

2.  Refractive error, visual acuity, and corneal-curvature changes in high and low myopes with orthokeratology treatment: A Malaysian study.

Authors:  Swee Lee Liong; Norhani Mohidin; Bay Wah Tan; Bariah Mohd Ali
Journal:  Taiwan J Ophthalmol       Date:  2015-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.